Abstract
Stroke is one of the main causes of death and disability in the world. However, there are still several medical limitations in stroke prevention, diagnosis and treatment. One promising field under investigation is the use of biomarkers to guide stroke etiology diagnosis and classification, since treatment differs among etiologic subtypes (cardioembolic, atherosclerotic and lacunar stroke) and many patients currently receive a diagnosis of undetermined stroke. In this article we update current knowledge about biomarkers related to specific stroke etiologies and discuss whether using a combination of biomarkers seems a feasible strategy for making an etiologic diagnosis in the acute phase of stroke. In the future, the use of these biomarkers will allow clinicians to rapidly guide other diagnostic tests and accelerate the onset of an optimal secondary prevention.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
